Personally, I’m eager to see what the 12 GBq doses show. If no dose-limiting toxicities are observed at that level then we’ve pulled clear of Pluvicto, which has served as a great comparator in many ways for 67Cu-SAR-bisPSMA and future marketability of Clarity.
Efficacy at 12GBq could be pretty special too!
Personally, I’m eager to see what the 12 GBq doses show. If no...
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.35 |
Change
0.220(5.33%) |
Mkt cap ! $1.352B | |||
| Open | High | Low | Value | Volume |
| $4.10 | $4.35 | $4.05 | $7.494M | 1.770M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2555 | $4.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.35 | 5589 | 4 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$4.25 |
Change
0.220 ( 3.26 %) |
||||
| Open | High | Low | Volume | ||
| $4.09 | $4.31 | $4.09 | 45313 | ||
| Last updated 15.58pm 24/05/2024 ? | |||||
| CU6 (ASX) Chart |